|
CA2152067A1
(en)
*
|
1992-12-18 |
1994-07-07 |
Boris Goldfarb |
Process and apparatus for etching an image within a solid article
|
|
US5521709A
(en)
*
|
1993-05-05 |
1996-05-28 |
International Business Machines Corporation |
Continuous barcode marking system
|
|
US5637244A
(en)
*
|
1993-05-13 |
1997-06-10 |
Podarok International, Inc. |
Method and apparatus for creating an image by a pulsed laser beam inside a transparent material
|
|
GB9324738D0
(en)
*
|
1993-12-02 |
1994-01-19 |
Oxley Dev Co Ltd |
Improvements to id systems
|
|
FR2717284B1
(fr)
*
|
1994-03-11 |
1996-04-05 |
Thomson Csf |
Carte magnétique et dispositif de lecture de cette carte.
|
|
WO1995025148A1
(en)
|
1994-03-17 |
1995-09-21 |
Hitachi Maxell, Ltd. |
Phosphor, phosphor composition, fluorescent mark carrier, and optical character reader
|
|
US5554974A
(en)
*
|
1994-11-23 |
1996-09-10 |
International Business Machines Corporation |
Encodable tag with radio frequency readout
|
|
US6239752B1
(en)
*
|
1995-02-28 |
2001-05-29 |
Stmicroelectronics, Inc. |
Semiconductor chip package that is also an antenna
|
|
GB2305075A
(en)
*
|
1995-09-05 |
1997-03-26 |
Ibm |
Radio Frequency Tag for Electronic Apparatus
|
|
DE19539355A1
(de)
*
|
1995-10-23 |
1997-04-24 |
Giesecke & Devrient Gmbh |
Verfahren zur Echtheitsprüfung eines Datenträgers
|
|
US5932119A
(en)
*
|
1996-01-05 |
1999-08-03 |
Lazare Kaplan International, Inc. |
Laser marking system
|
|
DE19606782C1
(de)
*
|
1996-02-23 |
1998-01-08 |
Orga Kartensysteme Gmbh |
Verfahren zur Herstellung einer Chipkarte und damit hergestellte Chipkarte
|
|
DE69738539T2
(de)
|
1996-12-03 |
2009-03-26 |
Amgen Fremont Inc. |
Vollkommen humane Antikörper die EGFR binden
|
|
AUPP231598A0
(en)
*
|
1998-03-13 |
1998-04-09 |
Mikoh Technology Limited |
A method of recording information ii
|
|
EP0985207A4
(en)
*
|
1997-04-03 |
2000-03-15 |
Mikoh Corp Limited |
INFORMATION RECORDING PROCEDURE
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
AU749161B2
(en)
*
|
1998-03-13 |
2002-06-20 |
Mikoh Technology Limited |
Method of recording information
|
|
WO2000000348A1
(en)
*
|
1998-06-29 |
2000-01-06 |
Recording Industry Association Of America |
Security marking system and method for minimizing pirating of data on data media
|
|
US5982282A
(en)
*
|
1998-09-16 |
1999-11-09 |
Sensormatic Electronics Corporation |
Product authentication indicia concealed in magnetomechanical EAS marker
|
|
AU772676B2
(en)
|
1998-12-23 |
2004-05-06 |
Amgen Fremont Inc. |
Human monoclonal antibodies to CTLA-4
|
|
US6833268B1
(en)
|
1999-06-10 |
2004-12-21 |
Abgenix, Inc. |
Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
|
|
JP4350237B2
(ja)
|
1999-11-08 |
2009-10-21 |
富士フイルム株式会社 |
カメラ
|
|
FR2811122B1
(fr)
*
|
2000-06-28 |
2005-05-20 |
Bernard Sala |
Dispositif de marquage de toiles et 'toile a puce' ainsi obtenue
|
|
US6616051B1
(en)
*
|
2000-06-28 |
2003-09-09 |
Authentic Ltd. |
Apparatus for and method for marking objects, objects marked thereby and apparatus and method of reading marked objects
|
|
US6855099B2
(en)
*
|
2001-10-31 |
2005-02-15 |
The Boeing Company |
Manufacturing system for aircraft structures and other large structures
|
|
AU2002348263B2
(en)
|
2001-11-30 |
2008-10-16 |
Amgen Fremont Inc. |
Transgenic animals bearing human IgLamda light chain genes
|
|
DK1613750T3
(en)
|
2003-03-19 |
2016-01-18 |
Amgen Fremont Inc |
ANTIBODIES TO T CELL AND MUCINDO immunoglobulin-binding domain 1 (TIM-1) antigen and uses thereof
|
|
US7736644B2
(en)
|
2003-06-27 |
2010-06-15 |
Amgen Fremont Inc. |
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
|
|
AU2005227313A1
(en)
|
2004-03-19 |
2005-10-06 |
Amgen Inc. |
Reducing the risk of human and anti-human antibodies through V gene manipulation
|
|
EP1838737B1
(en)
|
2004-12-20 |
2011-04-06 |
Amgen Fremont Inc. |
Binding proteins specific for human matriptase
|
|
EP2284194A1
(en)
|
2004-12-21 |
2011-02-16 |
AstraZeneca AB |
Antibodies directed to angiopoietin-2 and uses thereof
|
|
ES2395953T3
(es)
|
2005-01-26 |
2013-02-18 |
Amgen Fremont Inc. |
Anticuerpos frente a interleucina-1 beta
|
|
US7610872B2
(en)
*
|
2005-04-07 |
2009-11-03 |
Roman Coppola |
Tasting glasses having revealable indicators there on and method of conducting blind taste test
|
|
EP2548583A3
(en)
|
2005-11-10 |
2013-02-27 |
Curagen Corporation |
Method of treating ovarian and renal cancer using antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen
|
|
JP5302007B2
(ja)
|
2005-12-13 |
2013-10-02 |
アストラゼネカ アクチボラグ |
インスリン様増殖因子に特異的な結合タンパク質およびその使用
|
|
AR056857A1
(es)
|
2005-12-30 |
2007-10-24 |
U3 Pharma Ag |
Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
|
|
US8226878B2
(en)
*
|
2006-07-07 |
2012-07-24 |
University Of Central Florida Research Foundation, Inc. |
Laser processing of metal nanoparticle/polymer composites
|
|
CL2007002225A1
(es)
|
2006-08-03 |
2008-04-18 |
Astrazeneca Ab |
Agente de union especifico para un receptor del factor de crecimiento derivado de plaquetas (pdgfr-alfa); molecula de acido nucleico que lo codifica; vector y celula huesped que la comprenden; conjugado que comprende al agente; y uso del agente de un
|
|
DE102006042186A1
(de)
|
2006-09-08 |
2008-03-27 |
Giesecke & Devrient Gmbh |
Verfahren für die Vernichtung von Banknoten
|
|
US7615404B2
(en)
*
|
2006-10-31 |
2009-11-10 |
Intel Corporation |
High-contrast laser mark on substrate surfaces
|
|
JP2007082261A
(ja)
*
|
2006-11-22 |
2007-03-29 |
Fujifilm Corp |
カメラ
|
|
JOP20080381B1
(ar)
|
2007-08-23 |
2023-03-28 |
Amgen Inc |
بروتينات مرتبطة بمولدات مضادات تتفاعل مع بروبروتين كونفيرتاز سيتيليزين ككسين من النوع 9 (pcsk9)
|
|
EP2207809B1
(en)
|
2007-09-26 |
2013-07-03 |
U3 Pharma GmbH |
Heparin-binding epidermal growth factor-like growth factor antigen binding proteins
|
|
MY155621A
(en)
|
2007-11-12 |
2015-11-13 |
U3 Pharma Gmbh |
Axl antibodies
|
|
CA2735900A1
(en)
|
2008-09-19 |
2010-03-25 |
Medimmune, Llc |
Antibodies directed to dll4 and uses thereof
|
|
DK2504364T3
(da)
|
2009-11-24 |
2017-11-06 |
Medimmune Ltd |
Målrettede bindemidler mod b7-h1
|
|
SG10201600531TA
(en)
|
2011-01-24 |
2016-02-26 |
Univ Singapore |
Pathogenic mycobacteria-derived mannose-capped lipoarabinomannan antigen binding proteins
|
|
SG194111A1
(en)
|
2011-04-07 |
2013-11-29 |
Amgen Inc |
Novel egfr binding proteins
|
|
JOP20200043A1
(ar)
|
2011-05-10 |
2017-06-16 |
Amgen Inc |
طرق معالجة أو منع الاضطرابات المختصة بالكوليسترول
|
|
EP2734546A1
(en)
|
2011-07-18 |
2014-05-28 |
Amgen Inc. |
Apelin antigen-binding proteins and uses thereof
|
|
WO2013067060A1
(en)
|
2011-11-01 |
2013-05-10 |
Bionomics, Inc. |
Anti-gpr49 antibodies
|
|
WO2013075048A1
(en)
|
2011-11-16 |
2013-05-23 |
Amgen Inc. |
Methods of treating epidermal growth factor deletion mutant viii related disorders
|
|
EA039663B1
(ru)
|
2012-05-03 |
2022-02-24 |
Амген Инк. |
Применение антитела против pcsk9 для снижения сывороточного холестерина лпнп и лечения связанных с холестерином расстройств
|
|
KR20150030706A
(ko)
|
2012-06-11 |
2015-03-20 |
암젠 인코퍼레이티드 |
이중 수용체 길항 항원-결합 단백질 및 그것의 사용
|
|
ES2753950T3
(es)
|
2013-03-15 |
2020-04-15 |
Amgen Res Munich Gmbh |
Moléculas de unión monocatenarias que comprenden ABP del extremo N
|
|
WO2014209384A1
(en)
|
2013-06-28 |
2014-12-31 |
Amgen Inc. |
Methods for treating homozygous familial hypercholesterolema
|
|
JP6907124B2
(ja)
|
2015-04-17 |
2021-07-21 |
アムゲン リサーチ (ミュンヘン) ゲーエムベーハーAMGEN Research(Munich)GmbH |
Cdh3及びcd3に対する二重特異性抗体構築物
|
|
TWI829617B
(zh)
|
2015-07-31 |
2024-01-21 |
德商安美基研究(慕尼黑)公司 |
Flt3及cd3抗體構築體
|
|
TW202346349A
(zh)
|
2015-07-31 |
2023-12-01 |
德商安美基研究(慕尼黑)公司 |
Dll3及cd3抗體構築體
|
|
TWI796283B
(zh)
|
2015-07-31 |
2023-03-21 |
德商安美基研究(慕尼黑)公司 |
Msln及cd3抗體構築體
|
|
TWI744242B
(zh)
|
2015-07-31 |
2021-11-01 |
德商安美基研究(慕尼黑)公司 |
Egfrviii及cd3抗體構築體
|
|
TWI717375B
(zh)
|
2015-07-31 |
2021-02-01 |
德商安美基研究(慕尼黑)公司 |
Cd70及cd3抗體構築體
|
|
JOP20170091B1
(ar)
|
2016-04-19 |
2021-08-17 |
Amgen Res Munich Gmbh |
إعطاء تركيبة ثنائية النوعية ترتبط بـ cd33 وcd3 للاستخدام في طريقة لعلاج اللوكيميا النخاعية
|
|
US10762407B2
(en)
|
2017-04-05 |
2020-09-01 |
General Electric Company |
Component incorporating 3-D identification code
|
|
US10549347B2
(en)
|
2017-04-05 |
2020-02-04 |
General Electric Company |
System and method for authenticating components
|
|
US10703086B2
(en)
|
2017-04-05 |
2020-07-07 |
General Electric Company |
System and method for authenticating an additively manufactured component
|
|
US10943240B2
(en)
|
2017-04-05 |
2021-03-09 |
General Electric Company |
Additively manufactured component including a contrast agent for part identification
|
|
US10706139B2
(en)
|
2017-04-05 |
2020-07-07 |
General Electric Company |
System and method for authenticating components
|
|
US11090727B2
(en)
|
2017-04-05 |
2021-08-17 |
General Electric Company |
Additively manufactured component having surface features for part identification
|
|
JP2021532140A
(ja)
|
2018-07-30 |
2021-11-25 |
アムジェン リサーチ (ミュニック) ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Cd33及びcd3に結合する二重特異性抗体コンストラクトの長期投与
|
|
US11692031B2
(en)
|
2018-08-03 |
2023-07-04 |
Amgen Research (Munich) Gmbh |
Antibody constructs for CLDN18.2 and CD3
|
|
SG10202001721UA
(en)
|
2019-03-14 |
2020-10-29 |
Gen Electric |
Acoustic inspection device and method of operation
|
|
MX2022000988A
(es)
|
2019-07-26 |
2022-05-03 |
Amgen Inc |
Proteinas de union a antigeno anti-il13.
|
|
US11420259B2
(en)
|
2019-11-06 |
2022-08-23 |
General Electric Company |
Mated components and method and system therefore
|
|
FR3139218B1
(fr)
*
|
2022-08-24 |
2024-10-11 |
Commissariat Energie Atomique |
Procédés de marquage temporaire et d’identification d’un objet, objet identifiable correspondant
|